(Q33335556)

English

A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

A dose-escalation study of irinotecan (CPT-11) in combination with cisplatin in patients with advanced non-small cell lung cancer previously treated with a docetaxel-based front line chemotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Kakolyris

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

J Souglakos

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

S Agelaki

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

C H Kourousis

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

D Mavroudis

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

E Sarra

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

P Malliotakis

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

V Georgoulias

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 December 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

30

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

193-198

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

The clinical status of irinotecan (CPT-11), a novel water soluble camptothecin analogue: 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900146-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced antitumor efficacy of a combination of CPT-11, a new derivative of camptothecin, and cisplatin against human lung tumor xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900146-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of CPT-11 in combination with other anti-cancer agents in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900146-X

7 January 2021

based on heuristic

inferred from DOI database lookup

CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900146-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic study of irinotecan in combination with cisplatin for advanced lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900146-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale for the dosage and schedule of CPT-11 (irinotecan) selected for phase II studies, as determined by European phase I studies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900146-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous determination of the camptothecin analogue CPT-11 and its active metabolite SN-38 by high-performance liquid chromatography: application to plasma pharmacokinetic studies in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900146-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2800%2900146-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(00)00146-X

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33335556&oldid=1909470387"